immunity from liability; to regulate and prohibit the sale and offering for sale of drug paraphernalia under
certain circumstances; to provide for the implementation of federal law; to provide for penalties and
remedies; to provide for sanctions for violations of this act and local ordinances; to provide for an
appropriation and supplements; to repeal certain acts and parts of acts; to repeal certain parts of this act; and
to repeal certain parts of this act on specific dates,” by amending section 2891 (MCL 333.2891), as amended
by 2019 PA 89.
(The bill was enrolled on February 19, see House Journal No. 18, p. 255.)
Rep. Cole moved to reconsider the vote by which the House concurred in the Senate substitute (S-2).
The motion prevailed, a majority of the members serving voting therefor.
The question being on concurring in the substitute (S-2) made to the bill by the Senate,
The substitute (S-2) was concurred in, a majority of the members serving voting therefor, by yeas and nays,
as follows: